A retrospective study on prescription patterns and therapeutic approaches for various cancer chemotherapies in tertiary care hospital, Narasaraopet

Background: Cancer is a life-threatening disease that causes death. Cancer is the leading cause of death. There are several factors for the formation of cancers. According to survey conducted by the International Agency for Research on Cancer (IARC) and the American Cancer Society (ACS) in 2022 20 million new cancer cases are raised by 2022 and 9.7 million deaths. Aim/Objectives: This study assesses the prescription patterns and therapeutic approaches for various types of cancer. To evaluate the drug prescription patterns of Anti-Cancer drugs in cancer patients in tertiary care hospital, to observe different dose regimens, to study the efficacy of anti-cancer drugs in various cancer chemotherapies, and to determine the survival rate in cancer patients. Materials &methods: A retrospective observational study in a period of 5 months in a tertiary care hospital. Results: A total of 80 patients are enrolled in this study after diagnosed as the cancer. And majority of cancer patients are females. And cancer attacks majorly in the age group of 51-60. Cervix, and breast cancers in females are more. Based on the condition and severity of the patients the different types of cytotoxic drugs are used. Majorly the platinum-based drugs like cisplatin, carboplatin, and oxaliplatin are used. The drugs like ondansetron, dexamethasone, chlorpheniramine maleate, ranitidine, pantoprazole, and etc,. drugs are given to control or to suppress, the side effects caused by the cytotoxic drugs. Conclusion: The cytotoxic drugs are given in a controlled manner, there is a gap of 3 weeks for every chemotherapy cycle. The quality of life and survival rate can be increased by chemotherapy but there is a chance of death.